1.425
price up icon6.72%   0.085
 
loading
Schlusskurs vom Vortag:
$1.34
Offen:
$1.355
24-Stunden-Volumen:
7.88M
Relative Volume:
1.02
Marktkapitalisierung:
$909.66M
Einnahmen:
$29.48M
Nettoeinkommen (Verlust:
$-201.19M
KGV:
-4.4531
EPS:
-0.32
Netto-Cashflow:
$-216.50M
1W Leistung:
+11.72%
1M Leistung:
+26.55%
6M Leistung:
-1.38%
1J Leistung:
-63.61%
1-Tages-Spanne:
Value
$1.34
$1.44
1-Wochen-Bereich:
Value
$1.26
$1.44
52-Wochen-Spanne:
Value
$1.04
$3.99

Geron Corp Stock (GERN) Company Profile

Name
Firmenname
Geron Corp
Name
Telefon
(650) 473-7700
Name
Adresse
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Name
Mitarbeiter
229
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
GERN's Discussions on Twitter

Vergleichen Sie GERN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GERN
Geron Corp
1.425 855.40M 29.48M -201.19M -216.50M -0.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.64 115.43B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
747.39 78.44B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
872.32 52.42B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
390.58 51.68B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
201.83 42.80B 447.02M -1.18B -906.14M -6.1812

Geron Corp Stock (GERN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-10 Fortgesetzt Goldman Sell
2025-05-08 Herabstufung Scotiabank Sector Outperform → Sector Perform
2025-02-27 Herabstufung B. Riley Securities Buy → Neutral
2025-02-26 Herabstufung H.C. Wainwright Buy → Neutral
2024-11-05 Eingeleitet H.C. Wainwright Buy
2024-10-16 Eingeleitet Scotiabank Sector Outperform
2024-09-09 Eingeleitet Leerink Partners Outperform
2024-04-30 Herabstufung Robert W. Baird Outperform → Neutral
2024-04-29 Eingeleitet TD Cowen Buy
2024-03-15 Bestätigt Needham Buy
2023-09-12 Hochstufung Goldman Neutral → Buy
2023-03-28 Eingeleitet Goldman Neutral
2022-10-28 Eingeleitet Wedbush Outperform
2022-07-28 Fortgesetzt B. Riley Securities Buy
2021-11-02 Eingeleitet Robert W. Baird Outperform
2021-02-18 Fortgesetzt B. Riley Securities Buy
2020-08-03 Eingeleitet Stifel Buy
2019-11-19 Fortgesetzt B. Riley FBR Buy
2019-09-03 Eingeleitet H.C. Wainwright Buy
2019-08-15 Eingeleitet Cantor Fitzgerald Overweight
2019-04-09 Hochstufung Needham Hold → Buy
2019-01-31 Hochstufung B. Riley FBR Neutral → Buy
2018-10-02 Herabstufung B. Riley FBR Buy → Neutral
2018-07-05 Eingeleitet B. Riley FBR, Inc. Buy
2016-09-13 Bestätigt FBR & Co. Outperform
2016-09-13 Bestätigt FBR Capital Outperform
2015-12-07 Bestätigt Piper Jaffray Overweight
2015-04-21 Eingeleitet Oppenheimer Outperform
2014-06-12 Hochstufung MLV & Co Hold → Buy
2014-03-12 Herabstufung MLV & Co Buy → Hold
2013-12-10 Bestätigt MLV & Co Buy
2013-12-10 Hochstufung Needham Hold → Buy
2013-11-08 Bestätigt MLV & Co Buy
2013-10-16 Eingeleitet MLV & Co Buy
2012-08-30 Eingeleitet Stifel Nicolaus Buy
2012-06-28 Eingeleitet Needham Hold
Alle ansehen

Geron Corp Aktie (GERN) Neueste Nachrichten

pulisher
07:27 AM

14 Best Multibagger Penny Stocks to Buy Right Now - Insider Monkey

07:27 AM
pulisher
Dec 16, 2025

Squarepoint Ops LLC Increases Stock Position in Geron Corporation $GERN - MarketBeat

Dec 16, 2025
pulisher
Dec 12, 2025

Geron (NASDAQ:GERN) Trading Up 8.2%What's Next? - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025) - ts2.tech

Dec 12, 2025
pulisher
Dec 12, 2025

Geron stock falls as H.C. Wainwright reiterates Neutral rating amid restructuring - Investing.com

Dec 12, 2025
pulisher
Dec 12, 2025

Praxis tees up another approval filing; Geron turns to layoffs - Yahoo Finance

Dec 12, 2025
pulisher
Dec 12, 2025

Layoff Tracker: Pfizer, Geron Downsize To Streamline Costs - BioSpace

Dec 12, 2025
pulisher
Dec 12, 2025

Geron Corporation (NASDAQ:GERN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Dec 12, 2025
pulisher
Dec 11, 2025

Geron Corporation (GERN) Presents New Data at the 67th American Society of Hematology 2025 Annual Meeting - Yahoo Finance

Dec 11, 2025
pulisher
Dec 11, 2025

Foster City drug maker Geron to lay off one-third of staff under new CEOSan Francisco Business Times - The Business Journals

Dec 11, 2025
pulisher
Dec 11, 2025

Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On Sidelines (GERN) - Seeking Alpha

Dec 11, 2025
pulisher
Dec 11, 2025

Geron Corporation (GERN) Announces Significant Workforce Reducti - GuruFocus

Dec 11, 2025
pulisher
Dec 11, 2025

Geron (GERN) Initiates Strategic Restructuring for Long-Term Gro - GuruFocus

Dec 11, 2025
pulisher
Dec 11, 2025

Geron to cut workforce by one-third in strategic restructuring - Investing.com

Dec 11, 2025
pulisher
Dec 11, 2025

Geron Corporation Announces Strategic Restructuring to Enhance RYTELO® U.S. Commercial Strategy and Reduce Operating Expenses - Quiver Quantitative

Dec 11, 2025
pulisher
Dec 11, 2025

Geron (Nasdaq: GERN) plans one-third cut as 2026 operating expenses expected below 2025 - Stock Titan

Dec 11, 2025
pulisher
Dec 09, 2025

Geron stock rating reiterated as Neutral by H.C. Wainwright - Investing.com

Dec 09, 2025
pulisher
Dec 08, 2025

Geron (GERN) Highlights Promising ASH 2025 Data on RYTELO - GuruFocus

Dec 08, 2025
pulisher
Dec 08, 2025

Geron reports early cytopenia may signal response in MDS patients - Investing.com

Dec 08, 2025
pulisher
Dec 08, 2025

Geron Corporation Presents New Data on Imetelstat at ASH 2025, Highlighting Clinical Benefits in Lower-Risk Myelodysplastic Syndromes and Myelofibrosis - Quiver Quantitative

Dec 08, 2025
pulisher
Dec 08, 2025

Geron (Nasdaq: GERN) presents ASH 2025 RYTELO data on LR-MDS cytopenias, survival trends - Stock Titan

Dec 08, 2025
pulisher
Dec 04, 2025

How Geron Corporation (GON) stock correlates with oil marketsWeekly Gains Report & Daily Profit Focused Screening - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - Benzinga

Dec 04, 2025
pulisher
Dec 04, 2025

What consensus target says about Geron Corporation (GON) stockJuly 2025 EndofMonth & High Conviction Buy Zone Picks - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will Geron Corporation (GON) stock keep raising dividends2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Why Geron Corporation (GON) stock stays on buy listsStop Loss & Daily Stock Trend Reports - Newser

Dec 03, 2025
pulisher
Dec 01, 2025

Geron Corporation $GERN Stake Increased by Geode Capital Management LLC - MarketBeat

Dec 01, 2025
pulisher
Nov 26, 2025

Geron Corporation (NASDAQ:GERN) is favoured by institutional owners who hold 64% of the company - Yahoo Finance

Nov 26, 2025
pulisher
Nov 25, 2025

Geron Corporation $GERN Shares Sold by Segall Bryant & Hamill LLC - MarketBeat

Nov 25, 2025
pulisher
Nov 24, 2025

Wall Street Turns Bullish on Geron Corporation (GERN) amid Rytelo Sales Push Plans - Insider Monkey

Nov 24, 2025
pulisher
Nov 23, 2025

10 Fastest Growing Penny Stocks to Buy Now - Insider Monkey

Nov 23, 2025
pulisher
Nov 21, 2025

Geron Corporation (GERN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

Market reaction to Geron Corporation’s recent newsPortfolio Update Summary & Daily Stock Momentum Reports - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Geron Corporation stock gain from lower inflationWeekly Trend Recap & Weekly High Potential Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Geron Corporation (GON) stock extend growth storyWeekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why analysts maintain buy rating on Geron Corporation (GON) stockJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Geron’s Survival Strategy Faces Critical Test - AD HOC NEWS

Nov 20, 2025
pulisher
Nov 20, 2025

Will Geron Corporation stock rally after Fed decisions2025 Technical Overview & Fast Momentum Entry Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Geron Corporation (GON) stock is trending on social mediaWeekly Stock Summary & Weekly Market Pulse Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 19:45:31 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Geron Corporation (GON) stock resist broad market declinesIPO Watch & Advanced Swing Trade Entry Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Geron Corporation stock cheap at current valuationMarket Weekly Review & Target Return Focused Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 14:50:12 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 10:47:42 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Geron Corporation (GON) stock remains stable2025 Risk Factors & Expert Approved Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Patient Square Capital LP Acquires New Stake in Geron Corporation $GERN - MarketBeat

Nov 19, 2025
pulisher
Nov 19, 2025

Will Geron Corporation stock outperform growth indexesRate Hike & High Yield Equity Trading Tips - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will Geron Corporation stock deliver strong dividend growth2025 Market Outlook & Verified Swing Trading Watchlist - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Geron Corporation (NASDAQ:GERN) Given Average Rating of "Hold" by Analysts - MarketBeat

Nov 17, 2025
pulisher
Nov 16, 2025

Published on: 2025-11-16 22:14:00 - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

What hedge fund activity signals for Geron Corporation stockJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - newser.com

Nov 16, 2025

Finanzdaten der Geron Corp-Aktie (GERN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Geron Corp-Aktie (GERN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
LAWLIS V BRYAN
Director
May 09 '25
Buy
1.18
13,300
15,667
13,300
Samuels Scott Alan
EVP, Chief Legal Officer
Feb 27 '25
Buy
1.61
15,000
24,150
26,682
SCARLETT JOHN A
Chairman, President and CEO
Feb 27 '25
Buy
1.76
12,500
22,062
12,500
Ziegler James
EVP, Chief Commercial Officer
Feb 27 '25
Buy
1.60
100,000
160,000
100,000
$38.54
price up icon 0.12%
$97.59
price up icon 0.76%
$31.68
price up icon 1.02%
$92.87
price up icon 0.67%
biotechnology ONC
$305.25
price down icon 0.24%
$201.21
price up icon 0.22%
Kapitalisierung:     |  Volumen (24h):